Pregabalin Completed Phase 2 Trials for Diabetic Peripheral Neuropathy (DPN) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01496365Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy